Andrew X. Zhang
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Peptidase Inhibition and Analysis 4
-
- Protein Degradation and Inhibitors 6
- Ubiquitin and proteasome pathways 5
- Glycosylation and Glycoproteins Research 1
- Chemical Synthesis and Analysis 1
-
- Click Chemistry and Applications 5
- Synthesis and Biological Evaluation 2
- Co-authors
- David A. SpiegelPatrick J. McEnaneyJulien MichelWilliam L. JorgensenRyan P. MurelliChristopher G. ParkerM. Paola CastaldiKévin Moreau
- Journals
- Journal of the American Chemical Society (3 papers)International Journal of Molecular Sciences (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- United StatesSwedenGermany
In The Last Decade
Andrew X. Zhang
15 papers receiving 671 citations
Peers
Comparison fields: 5 of 64
- Radiology, Nuclear Medicine and Imaging 252
- Oncology 191
- Molecular Biology 462
- Immunology 90
- Hematology 45
Countries citing papers authored by Andrew X. Zhang
This map shows the geographic impact of Andrew X. Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew X. Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew X. Zhang more than expected).
Fields of papers citing papers by Andrew X. Zhang
This network shows the impact of papers produced by Andrew X. Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew X. Zhang. The network helps show where Andrew X. Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Andrew X. Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2023 | 8 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 14 | |
| 6 | 2021 | 4 | |
| 7 | 2020 | 10 | |
| 8 | 2020 | 158 | |
| 9 | 2019 | 64 | |
| 10 | 2018 | 6 | |
| 11 | 2017 | 1 | |
| 12 | 2014 | 36 | |
| 13 | 2012 | 118 | |
| 14 | 2011 | 24 | |
| 15 | 2010 | 131 | |
| 16 | 2009 | 101 |
About Andrew X. Zhang
Andrew X. Zhang is a scholar working on Radiology, Nuclear Medicine and Imaging, Organic Chemistry and Molecular Biology, having authored 16 papers that have together received 680 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (6 papers), Click Chemistry and Applications (5 papers), Ubiquitin and proteasome pathways (5 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Peptidase Inhibition and Analysis (4 papers), Synthesis and Biological Evaluation (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (252 citations), Oncology (191 citations) and Molecular Biology (462 citations). Andrew X. Zhang has collaborated with scholars based in United States, Sweden and Germany. Frequent co-authors include David A. Spiegel, Patrick J. McEnaney, Julien Michel, William L. Jorgensen, Ryan P. Murelli, Christopher G. Parker, M. Paola Castaldi, Kévin Moreau, Fiona Pachl and Göran Dahl. Their work appears in journals such as Journal of the American Chemical Society, International Journal of Molecular Sciences and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.